Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RELPAX vs REMIFENTANIL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RELPAX vs REMIFENTANIL: Safety Overview

Metric RELPAX REMIFENTANIL
Total FAERS Reports 135 2,733
Deaths Reported 1 210
Death Rate 0.7% 7.7%
Hospitalizations 11 995
Average Patient Age 47.4 yrs 50.3 yrs
% Female Patients N/A 48.2%
FDA Approval Date N/A Jan 16, 2018
Manufacturer N/A Fresenius Kabi USA, LLC
Route N/A INTRAVENOUS
Marketing Status N/A Prescription